Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × ficlatuzumab × Clear all

Phase

Status

Completed 3 Withdrawn 1 Terminated 1 Recruiting 1 No longer available 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Paclitaxel 31 Cyclophosphamide 30 Cisplatin 29 Carboplatin 27 Bevacizumab 27 Fluorouracil 24 pembrolizumab 21 Nivolumab 21 Leucovorin 20 Rituximab 19 avelumab 18 Gemcitabine 18 Docetaxel 18 Dexamethasone 18 Capecitabine 17 130-nm albumin-bound paclitaxel 14 ALT-803 13 Oxaliplatin 12 Cetuximab 12 fludarabine 11 Ipilimumab 11 venetoclax 10 atezolizumab 10 Radiosurgery 10 Radiotherapy 9 Pemetrexed 9 Omacor 9 Lenalidomide 9 Bendamustine Hydrochloride 9 yeast-CEA vaccine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04100330 2020-03-31

CyFi2

AVEO Pharmaceuticals, Inc.

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡